Camizestrant and ctDNA-Guided Treatment Switching: A New Paradigm in ESR1-Mutant Advanced Breast Cancer
Sep 06, 2026
View online
Camizestrant and ctDNA-Guided Treatment Switching: A New Paradigm in ESR1-Mutant Advanced Breast Cancer
Nicole Engelbrecht: UICC’s New Ten Year Strategy for 2026-2036 Has Been Published
Giannis Mountzios: Combination of TCEs and ADCs Holds Promise for Deep and Durable Responses in ES-SCLC
Bob Li Highlights a Major Step Toward More Equitable Cancer Trials
“An Evening for Cure” Gala in Maryland Supports $100M Otumfuo Osei Tutu II Cancer Center in Ghana
OncoDaily Partners with World Radiotherapy Awareness Day to Champion Access, Awareness and Better Cancer Care
Busy Philipps Reveals Oligodendroglioma Diagnosis: Symptoms, Treatment and Prognosis
VIRO 2026 – Global Voices in Renal Oncology
CDMRP Ovarian Cancer Academy Early-Career Investigator Award 2026
AACR–QuadW Foundation Sarcoma Research Fellowship 2027
NCI Cancer Biomarkers Branch Day: Celebrating 30+ Years of Cancer Biomarkers Research
3rd Symposium: Artificial Intelligence in Public Health Research
The Voice of Oncology
Unsubscribe
|
Manage subscription
OncoDaily, P53 Inc.
867 Boylston Street, 5th Floor, Suite 1094, Boston, MA 02116
Copyright (C) 2023-2026. OncoDaily, P53 Inc. All rights reserved.
